Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.37 |
| ▸ | LMNA | P02545 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6707839 | 0.91 | RXFP1 (0.49) | RXFP1ALDH1A1LMNAKDM4EPKM | |
| SCHEMBL6710165 | 0.90 | ALDH1A1 (0.40) | RXFP1ALDH1A1LMNAKDM4EGRIK1 | |
| SCHEMBL6710040 | 0.88 | CSF1R (0.38) | ALDH1A1LMNAKDM4EPKMGAA | |
| SCHEMBL6709887 | 0.87 | GRIK1 (0.43) | ALDH1A1LMNAGRIK1MAPTSMN1; SMN2 | |
| SCHEMBL6714364 | 0.86 | HIF1A (0.45) | ALDH1A1LMNAGRIK1MAPTSMN1; SMN2 | |
| SCHEMBL6713596 | 0.86 | RXFP1 (0.37) | RXFP1ALDH1A1LMNAKDM4EPKM | |
| SCHEMBL6709000 | 0.85 | GRIK1 (0.40) | LMNAGRIK1MAPTSMN1; SMN2HIF1A | |
| SCHEMBL6714102 | 0.84 | GPR27 (0.42) | GRIK1PKMMAPTHIF1A | |
| SCHEMBL6709874 | 0.84 | GRIK1 (0.39) | GRIK1MAPTSMN1; SMN2HIF1ARAB9A | |
| SCHEMBL6710405 | 0.83 | ALB (0.46) | RXFP1ALDH1A1LMNAKDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | RXFP1 3836/4885ALDH1A1 123/4885LMNA 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.